Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不继发性白血病的发迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不继发性白血病的发迹象。
声明:以上例句、词性分类均由互联网资源成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。